News >

MRD: A Key Predictor of Clinical Outcomes in Acute Lymphoblastic Leukemia

Kristi Rosa
Published: Tuesday, Jul 09, 2019

Annie Im, MD

Annie Im, MD

Assessing for minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) is imperative, as it can be used to predict clinical outcomes, such as relapse and survival in patients, said Annie Im, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication